Samsung Genome Institute Data Access Committee

woongyang.park@samsung.com

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001005978	To identify the therapeutic targets in a treatment-refractory cancer patient, we performed single-cell RNA sequencing for 3,115 cells from primary bladder cancer (BC159-T#3) and patient-derived xenografts (BC159-T#3-PDX-vehicle and BC159-T#3-PDX-tipifarnib). Matched time-series bulk tumor tissues were also sequenced using whole exome target probe (WES) and whole transcriptome target probe (WTS).	Illumina HiSeq 2500	10